share_log

金河生物(002688.SZ):公司对2024年整体经营情况和实现业绩指标具有充足信心

Jinhe Biotech (002688.SZ): The company has full confidence in the overall business situation and achievement of performance indicators in 2024

Gelonghui Finance ·  May 6 21:44

Gelonghui May 7 丨 Jinhe Biotech (002688.SZ) Investor Relations Activity Record Sheet shows that the company's revenue did not increase year-on-year in the first quarter, mainly due to the fact that the downstream aquaculture industry was still sluggish, and the first quarter was relatively low season for the industry. In 2024, the company formulated the 2024 financial budget plan based on reasonable predictions and judgments on the economic situation and upstream and downstream industries. We believe that upstream raw materials and energy prices are still on a downward trend, pig prices are expected to continue to rise, and the downstream farming industry is expected to break out of the slump. The company's new chemicals and vaccines (doxycycline, vaccine) will generate incremental revenue. In addition, the company's US business is developing rapidly and is booming, and the management team's incentives are practical, so overall, the company has full confidence in the overall business situation and achievement of performance indicators in 2024.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment